CVM Share Price

Open 0.00 Change Price %
High 0.12 1 Day 0.00 0.00
Low 0.11 1 Week 0.01 9.09
Close 0.12 1 Month -0.17 -58.62
Volume 2702730 1 Year -0.32 -72.73
52 Week High 0.66
52 Week Low 0.10
CVM Important Levels
Resistance 2 0.13
Resistance 1 0.13
Pivot 0.12
Support 1 0.11
Support 2 0.11
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
NAK 1.75 -8.38%
NAK 1.75 -8.38%
RBY 0.03 -70.00%
PBTH 8.23 0.37%
NGD 3.80 -2.81%
NGD 3.80 -2.81%
SYRG 9.82 -0.30%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
CPHI 0.29 52.63%
IGC 0.33 37.50%
IGC 0.33 37.50%
IGC 0.33 37.50%
MBA 0.20 25.00%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
INV 0.14 -17.65%
More..

Cel-Sci Corporation (AMEX: CVM)

CVM Technical Analysis 5
As on 9th Dec 2016 CVM Share Price closed @ 0.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.44 & Strong Sell for SHORT-TERM with Stoploss of 0.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
CVM Target for December
1st Target up-side 0.26
2nd Target up-side 0.29
3rd Target up-side 0.33
1st Target down-side 0.16
2nd Target down-side 0.13
3rd Target down-side 0.09
CVM Other Details
Segment EQ
Market Capital 100737896.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cel-sci.com
CVM Address
CVM
8229 Boone Boulevard
Suite 802
Vienna, VA 22182
United States
Phone: 703-506-9460
Fax: 703-506-9471
Interactive Technical Analysis Chart Cel-Sci Corporation ( CVM AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cel-Sci Corporation
CVM Business Profile
CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. Multikine is also being used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. In addition, it is developing Ligand Epitope Antigen Presentation System (LEAPS), a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, is developing a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.